Search Results
Showing Results for Arrhythmia
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
On April 25, 2025, the FDA approved the OmniaSecure defibrillation lead, a 1.6 mm, catheter-delivered, lumenless lead for right ventricular implantation. The small-diameter lead is designed to connect to an implantable defibrillator and treat ventricular tachyarrhythmias, ventricular fibrillation, and bradyarrhythmias, with LEADR trial data showing high implant success, safety, and electrical performance.
In this Q&A, he shares insights into his career journey, the experiences that shaped his path and what excites him most about the future of cardiology.
It is with pride and gratitude that we reflect on the remarkable 10-year journey of European Journal of Arrhythmia & Electrophysiology. With the vital contributions of all of our esteemed authors, reviewers and editorial board members, the journal has served ...
Postural tachycardia syndrome (PoTS) is a chronic condition, predominately affecting women between the ages of 15 and 50, and prevalence is estimated to be 0.2%.1,2 It is characterised by an abnormal response by the autonomic nervous system to changes in posture causing lightheadedness ...
As 2024 draws to a close, we’re celebrating a wonderful year of content. From insightful expert Q&As and peer-reviewed articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the cardiology community with high-quality, easily accessible content.
Visionary Voices: Season 1, Episode 7 Join us in this episode as Trudie Lobban, Founder and Trustee of Arrhythmia Alliance, discusses the remarkable work of Pace4Life. This innovative charity repurposes cardiac electronic devices, delivering critical heart care to communities in low- ...
touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.
A recent study has uncovered a significant association between residential exposure to transportation noise and the risk of developing atrial fibrillation (AF). The study, published in The Lancet Regional Health - Europe reveals that individuals exposed to elevated levels of road traffic noise face a 2% increase in the risk of AF for every 10-decibel rise in noise exposure. Notably, this risk was amplified among women and those with higher body mass indices, underscoring the need for heightened awareness of environmental health risks.
A recent study by Ryan Woltzand colleagues from the Howard Hughes Medical Institute (CA, USA) in PNAS reveals that phosphatidylinositol 4,5-bisphosphate (PIP2) plays a critical role in regulating small-conductance Ca²+-activated K⁺ (SK2) channels by disrupting a key salt bridge that modulates channel activation. This discovery not only enhances our understanding of ion channel dynamics but also holds significant promise for the development of targeted therapies for atrial fibrillation (AF).
We’re looking forward to the Heart Rhythm Congress, which is taking place in Birmingham, UK between 6-8 October 2024. Promising attendees an opportunity to explore the largest heart rhythm conference in the UK. We are excited to provide independent, expert ...
The Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation (BEAT-AF) treatment project is an initiative funded by the European Commission from the European Union's Horizon 2020 research and innovation programme, and managed under the European Health and Digital Executive Agency (grant number 945125).1,2 The ...
A recent study published in Nature Medicine has provided compelling evidence that wearable devices can play a crucial role in managing atrial fibrillation (AF) in elderly patients.
The ESC Congress is a key event in our conference calendar, and this year, London will welcome thousands of cardiologists and allied healthcare professionals. Together, they will work to transform patient care and advance the field through cutting-edge research, pioneering technologies, and collaborative initiatives.
Highlights The autonomic nervous system plays a critical role in the aetiopathogenesis of atrial fibrillation (AF). Neuromodulation of the autonomic nervous system has been a topic of increased interest in the management of AF. Ablation of ganglionated plexi, ethanol ablation ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
